19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Lysophosphatidic acid signaling through its receptor initiates pro-fibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The expansion of the fibroblast pool is a critical step in organ fibrosis, but the mechanisms driving expansion remain to be fully clarified. We previously showed that lysophosphatidic acid (LPA) signaling through its receptor LPA 1 expressed on fibroblasts directly induces the recruitment of these cells. Here we tested whether LPA-LPA 1 signaling drives fibroblast proliferation and activation during the development of renal fibrosis. LPA 1-deficient (LPA 1−/−) or -sufficient (LPA 1+/+) mice were crossed to mice with green fluorescent protein expression (GFP) driven by the type I pro-collagen promoter (Col-GFP) to identify fibroblasts. Unilateral ureteral obstruction-induced increases in renal collagen were significantly, though not completely, attenuated in LPA 1−/−Col-GFP mice, as were the accumulations of both fibroblasts and myofibroblasts. Connective tissue growth factor was detected mainly in tubular epithelial cells, and its levels were suppressed in LPA 1 −/−Col-GFP mice. LPA-LPA 1 signaling directly induced connective tissue growth factor expression in primary proximal tubular epithelial cells, through a myocardin-related transcription factor-serum response factor pathway. Proximal tubular epithelial cell derived connective tissue growth factor mediated renal fibroblast proliferation and myofibroblast differentiation. Administration of an inhibitor of myocardin-related transcription factor/serum response factor suppressed obstruction-induced renal fibrosis. Thus, targeting LPA-LPA 1 signaling and/or myocardin-related transcription factor/serum response factor-induced transcription could be promising therapeutic strategies for renal fibrosis.

          Related collections

          Author and article information

          Journal
          0323470
          5428
          Kidney Int
          Kidney Int.
          Kidney international
          0085-2538
          1523-1755
          10 November 2016
          04 December 2016
          March 2017
          01 March 2018
          : 91
          : 3
          : 628-641
          Affiliations
          [1 ]Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114
          [2 ]Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114
          [3 ]Fibrosis Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114
          [4 ]Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114
          [5 ]Division of Nephrology, Kanazawa University Hospital, Kanazawa, Japan 920-8641
          [6 ]Division of Blood Purification, Kanazawa University Hospital, Kanazawa, Japan 920-8641
          [7 ]Department of Laboratory Medicine and Nephrology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan 920-8641
          [8 ]Department of Molecular Biology, Helen L. Dorris Institute for Neurological and Psychiatric Disorders, The Scripps Research Institute, La Jolla, CA 92037
          [9 ]Division of Nephrology, Department of Medicine, Center for Lung Biology and Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109
          [10 ]Biogen, Cambridge, MA 02139
          Author notes
          Address correspondence to: Norihiko Sakai, M.D., Ph.D., Division of Nephrology, Division of Blood Purification, Kanazawa University Hospital, Kanazawa, Japan 920-8641; norin0826@ 123456yahoo.co.jp ; Tel: 81-76-265-2233; Fax: 81-76-234-4250 or Andrew M. Tager, M.D., Fibrosis Research Center, Massachusetts General Hospital, 149 13 th Street, Room 8301, Charlestown, MA 02129; amtager@ 123456mgh.harvard.edu ; Tel: (617) 724-7368; Fax: (617) 726-5651
          Article
          PMC5313343 PMC5313343 5313343 nihpa825095
          10.1016/j.kint.2016.09.030
          5313343
          27927603
          3de8811f-b59b-4a02-b92b-7d2261dfbf2d
          History
          Categories
          Article

          Fibrosis,fibroblast,LPA1 ,CTGF
          Fibrosis, fibroblast, LPA1 , CTGF

          Comments

          Comment on this article